Sale

Canada Diabetes Market

Canada Diabetes Market Size, Share, Demand, Growth, Forecast: By Segment: Canada Oral Antidiabetics Market, Canada Insulin Market; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Value Chain Analysis; Competitive Landscape; 2024-2032

Canada Diabetes Market Outlook

The Canada diabetes market is growing at a CAGR of 8.4% between 2021 and 2026. The industry contributes to the growth of the North America diabetic devices market, which attained a value of USD 9.7 billion in the year 2020 and is expected to grow at a CAGR of 9% in the forecast period of 2024-2032 to reach USD 16.3 billion by 2026.

 

Canada Diabetes Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America is a significant market for diabetes, which has witnessed an exponential growth of diabetes patients in recent years. The developed countries in North America, namely Canada and the United States, have a high rate of diabetes, mainly due to lifestyle changes. On account of this, the sale of insulin, a diabetic device, has rapidly increased in the region. Insulin, which was initially used to treat type 1 diabetic patients exclusively, is now used as a treatment method by a substantial amount of type 2 patients.

 

Market Segmentation

Diabetes is referred to as a chronic ailment caused by the sugar spikes in the body due to inappropriate production of or response of the body to insulin. Diabetes has adverse effects on the body's ability to break down sugar absorbed from food or generate an adequate amount of insulin. Uncontrolled diabetes can cause a variety of problems, such as visual, renal, cardiovascular, and neural disorders.

 

Canada Diabetes Market By Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the segment, the Canada diabetes market is divided into:

  • Canada Oral Antidiabetics Market
  • Canada Insulin Market

The regional markets can be divided into British Columbia, Alberta, the Prairies, Central Canada, and Atlantic Canada.

 

Canada Diabetes Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The Canada diabetes market is driven by the rising rate of obesity, spurring stress levels, and inefficient exercise within the country. The industry is further aided by the rising demand for insulin, which has resulted in tremendous R&D activities in producing various painless types of insulin deliverable devices, like integrated insulin pumps, continuous glucose monitoring (CGM), improved lancets for a glucometer, and enormously accurate blood glucose monitoring devices (for instance, the flash glucose monitoring device).

The Canada diabetes market is witnessing a growth due to various advancements taking place in the industry. Initially, the insulin was given through syringes, which are considered painful and hard to use. Now, companies like Sanofi and Novo Nordisk, among others, have innovated insulin pens with a specific set dosage. Usage of this pen reduces insulin wastage and is less painful to use. The only drawback that might affect the Canada diabetes market growth is the high cost of insulin pens.

 

Competitive Landscape

The report gives a detailed analysis of the following key players in the Canada diabetes market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche Ltd
  • Medtronic Canada
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model, along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Segment
  • Region
Breakup by Segment
  • Canada Oral Antidiabetics Market
  • Canada Insulin Market
Breakup by Region
  • British Columbia
  • Alberta
  • The Prairies
  • Central Canada
  • Atlantic Canada
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche Ltd
  • Medtronic Canada
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Canada
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Canada Diabetes Epidemiology

    8.1    Diabetes Population and Prevalence Rates
    8.2    Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
    8.3    Population and Prevalence Rates by Region
    8.4    Population and Prevalence Rates by Gender
    8.5    Population and Prevalence Rates by Age Group
9    Canada Diabetes Market Analysis
    9.1    Key Industry Highlights
    9.2    Canada Diabetes Historical Market (2018-2023) 
    9.3    Canada Diabetes Market Forecast (2024-2032)
    9.4    Canada Diabetes Market by Segment
        9.4.1    Canada Oral Antidiabetics Market
            9.4.1.1    Historical Trend (2018-2023)
            9.4.1.2    Forecast Trend (2024-2032)
            9.4.1.3    Market by Class
            9.4.1.4    Market Share by Key Players
        9.4.2    Canada Insulin Market
            9.4.2.1    Historical Trend (2018-2023)
            9.4.2.2    Forecast Trend (2024-2032)
            9.4.2.3    Market by Class
            9.4.2.4    Market Share by Key Players
    9.5    Canada Diabetes Market by Region
        9.5.1    British Columbia
        9.5.2    Alberta
        9.5.3    The Prairies
        9.5.4    Central Canada
        9.5.5    Atlantic Canada
10    Regional Analysis
    10.1    British Columbia
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Alberta
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    The Prairies
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Central Canada
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5    Atlantic Canada
        10.5.1    Historical Trend (2018-2023)
        10.5.2    Forecast Trend (2024-2032)
11    Market Dynamics
    11.1    SWOT Analysis
        11.1.1    Strengths
        11.1.2    Weaknesses
        11.1.3    Opportunities
        11.1.4    Threats
    11.2    Porter’s Five Forces Analysis
        11.2.1    Supplier’s Power
        11.2.2    Buyers Power
        11.2.3    Threat of New Entrants
        11.2.4    Degree of Rivalry
        11.2.5    Threat of Substitutes
    11.3    Key Indicators for Demand
    11.4    Key Indicators for Price
12    Value Chain Analysis
13    Competitive Landscape

    13.1    Market Structure
    13.2    Company Profiles
        13.2.1    Abbott
            13.2.1.1    Company Overview
            13.2.1.2    Demographic Reach and Achievements
            13.2.1.3    Certifications
        13.2.2    Dexcom
            13.2.2.1    Company Overview
            13.2.2.2    Demographic Reach and Achievements
            13.2.2.3    Certifications
        13.2.3    F. Hoffmann-La Roche Ltd
            13.2.3.1    Company Overview
            13.2.3.2    Demographic Reach and Achievements
            13.2.3.3    Certifications
        13.2.4    Medtronic Canada
            13.2.4.1    Company Overview
            13.2.4.2    Demographic Reach and Achievements
            13.2.4.3    Certifications
        13.2.5    Others
14    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Canada Diabetes Market: Key Industry Highlights, 2018 and 2032
2.    Canada Diabetes Epidemiology: Diabetes Population and Prevalence Rates
3.    Canada Diabetes Epidemiology: Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
4.    Canada Diabetes Epidemiology: Population and Prevalence Rates by Region
5.    Canada Diabetes Epidemiology: Population and Prevalence Rates by Gender
6.    Canada Diabetes Epidemiology: Population and Prevalence Rates by Age Group
7.    Canada Diabetes Historical Market: Breakup by Segment (USD Billion), 2018-2023
8.    Canada Diabetes Market Forecast: Breakup by Segment (USD Billion), 2024-2032
9.    Canada Diabetes Historical Market: Breakup by Region (USD Billion), 2018-2023
10.    Canada Diabetes Market Forecast: Breakup by Region (USD Billion), 2024-2032
11.    Canada Diabetes Market Structure

Key Questions Answered in the Report

The industry contributes to the growth of the North America diabetic devices market, which attained a value of USD 9.7 billion in the year 2020.

The market is projected to grow at a CAGR of nearly 8.4% in the forecast period of 2024-2032.

The market is estimated to be aided by the North America diabetes market, which is expected to reach a value of about USD 16.3 billion by 2026, growing at CAGR of 9% between 2021 and 2026.

The major drivers of the market include rising prevalence of diabetes, increasing population, rising demand for insulin, and growing stress levels.

Technological advancements taking place for diabetes detection, monitoring, and treatment and rising rate of obesity are expected to be key trends guiding the growth of the market.

British Columbia, Alberta, the Prairies, Central Canada, and Atlantic Canada are the leading regions in the market.

The major segments of the market are the Canada oral antidiabetics market and the Canada insulin market.

The leading players in the Canada diabetes market are Abbott, Dexcom, F. Hoffmann-La Roche Ltd, and Medtronic Canada, among others.

Analyst Review

The Canada diabetes market contributes to the growth of the North America diabetic devices market, which attained a value of USD 9.7 billion in the year 2020, driven by the rising rate of obesity and inefficient exercise levels. Aided by the technological advancements, the North America diabetic devices market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 9%, thus, further boosting the Canada diabetes market.

EMR's meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its segments, the industry for diabetes in Canada can be segmented into Canada oral antidiabetics and insulin markets. The major regional markets in the industry in Canada are British Columbia, Alberta, the Prairies, Central Canada, and Atlantic Canada. The key players in the above industry include Abbott, Dexcom, F. Hoffmann-La Roche Ltd, and Medtronic Canada, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 1999     $1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3999     $3699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6299     $5699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 8499     $7699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER